Get the latest news on Neurizon Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on PAAFF performance

Latest Neurizon Therapeutics Stock News | OTC:PAAFF | Benzinga

Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

NEURIZON THERAPEUTICS LTD by NEURIZON THERAPEUTICS LTD.

Comments

Neurizon Therapeutics Stock News

News

Latest Neurizon Therapeutics Stock News | OTC:PAAFF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga